tiprankstipranks
Trending News
More News >
Enzo Biochem, Inc. (ENZB)
:ENZB
Advertisement

Enzo Biochem (ENZB) Stock Statistics & Valuation Metrics

Compare
189 Followers

Total Valuation

Enzo Biochem has a market cap or net worth of $35.74M. The enterprise value is $1.97M.
Market Cap$35.74M
Enterprise Value$1.97M

Share Statistics

Enzo Biochem has 52,352,764 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding52,352,764
Owned by Insiders12.07%
Owned by Institutions13.44%

Financial Efficiency

Enzo Biochem’s return on equity (ROE) is -0.46 and return on invested capital (ROIC) is -42.14%.
Return on Equity (ROE)-0.46
Return on Assets (ROA)-0.30
Return on Invested Capital (ROIC)-42.14%
Return on Capital Employed (ROCE)-0.16
Revenue Per Employee255.26K
Profits Per Employee-208.62K
Employee Count125
Asset Turnover0.37
Inventory Turnover2.53

Valuation Ratios

The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.
PE Ratio
PS Ratio0.00
PB Ratio0.82
Price to Fair Value1.03
Price to FCF-2.18
Price to Operating Cash Flow-2.33
PEG Ratio-0.69

Income Statement

In the last 12 months, Enzo Biochem had revenue of 31.91M and earned -26.08M in profits. Earnings per share was -0.51.
Revenue31.91M
Gross Profit14.63M
Operating Income-9.82M
Pretax Income-9.82M
Net Income-26.08M
EBITDA-8.35M
Earnings Per Share (EPS)-0.51

Cash Flow

In the last 12 months, operating cash flow was -15.32M and capital expenditures -1.03M, giving a free cash flow of -16.35M billion.
Operating Cash Flow-15.32M
Free Cash Flow-16.35M
Free Cash Flow per Share-0.31

Dividends & Yields

Enzo Biochem pays an annual dividend of $0.1, resulting in a dividend yield of ―
Dividend Per Share$0.1
Dividend Yield
Payout Ratio-25.00%
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta1.90
52-Week Price Change-35.24%
50-Day Moving Average0.62
200-Day Moving Average0.68
Relative Strength Index (RSI)68.22
Average Volume (3m)697.65K

Important Dates

Enzo Biochem upcoming earnings date is Oct 21, 2025, After Close (Confirmed).
Last Earnings DateJun 16, 2025
Next Earnings DateOct 21, 2025
Ex-Dividend DateNov 15, 2024

Financial Position

Enzo Biochem as a current ratio of 2.82, with Debt / Equity ratio of 6.92%
Current Ratio2.82
Quick Ratio2.55
Debt to Market Cap<0.01
Net Debt to EBITDA5.85
Interest Coverage Ratio-49.83

Taxes

In the past 12 months, Enzo Biochem has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate-1.66

Enterprise Valuation

Enzo Biochem EV to EBITDA ratio is -1.10, with an EV/FCF ratio of -0.34.
EV to Sales0.29
EV to EBITDA-1.10
EV to Free Cash Flow-0.34
EV to Operating Cash Flow-0.35

Balance Sheet

Enzo Biochem has $36.69M in cash and marketable securities with $3.00M in debt, giving a net cash position of -$33.69M billion.
Cash & Marketable Securities$36.69M
Total Debt$3.00M
Net Cash-$33.69M
Net Cash Per Share-$0.64
Tangible Book Value Per Share$1.10

Margins

Gross margin is 43.75%, with operating margin of -30.77%, and net profit margin of -81.73%.
Gross Margin43.75%
Operating Margin-30.77%
Pretax Margin-30.77%
Net Profit Margin-81.73%
EBITDA Margin-26.16%
EBIT Margin-30.15%

Analyst Forecast

The average price target for Enzo Biochem is $0.50, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target$0.50
Price Target Upside-26.47% Downside
Analyst ConsensusHold
Analyst Count0
Revenue Growth Forecast
EPS Growth Forecast

Scores

Smart Score4
AI Score54
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis